These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24276847)

  • 1. Neuraminidase inhibitors for critically ill children with influenza.
    Louie JK; Yang S; Samuel MC; Uyeki TM; Schechter R
    Pediatrics; 2013 Dec; 132(6):e1539-45. PubMed ID: 24276847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.
    Louie JK; Yang S; Acosta M; Yen C; Samuel MC; Schechter R; Guevara H; Uyeki TM
    Clin Infect Dis; 2012 Nov; 55(9):1198-204. PubMed ID: 22843781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    PLoS One; 2012; 7(9):e43491. PubMed ID: 22984431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.
    Lee N; Leo YS; Cao B; Chan PK; Kyaw WM; Uyeki TM; Tam WW; Cheung CS; Yung IM; Li H; Gu L; Liu Y; Liu Z; Qu J; Hui DS
    Eur Respir J; 2015 Jun; 45(6):1642-52. PubMed ID: 25573405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays.
    Nguyen HT; Sheu TG; Mishin VP; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3671-7. PubMed ID: 20585136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
    Takemoto Y; Asai T; Ikezoe I; Yano T; Ichikawa M; Miyagawa S; Matsumoto J
    Chemotherapy; 2013; 59(5):373-8. PubMed ID: 24821568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
    Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM
    PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
    Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
    Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Clinical Courses of Patients with Influenza after Neuraminidase Inhibitors Treatment: A Postcard Survey of the 2013-2014 Influenza Season in Osaka.
    Yoshi N; Tocino Y; Fujioka M; Kureya Y; Asai K; Kimura T; Shinataku H; Hirata K
    Osaka City Med J; 2016 Dec; 62(2):29-38. PubMed ID: 30550708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
    Muthuri SG; Venkatesan S; Myles PR; Leonardi-Bee J; Al Khuwaitir TS; Al Mamun A; Anovadiya AP; Azziz-Baumgartner E; Báez C; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Denholm JT; Dominguez SR; Duarte PA; Dubnov-Raz G; Echavarria M; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Iglesias AL; Hoger PH; Hu X; Islam QT; Jiménez MF; Kandeel A; Keijzers G; Khalili H; Knight M; Kudo K; Kusznierz G; Kuzman I; Kwan AM; Amine IL; Langenegger E; Lankarani KB; Leo YS; Linko R; Liu P; Madanat F; Mayo-Montero E; McGeer A; Memish Z; Metan G; Mickiene A; Mikić D; Mohn KG; Moradi A; Nymadawa P; Oliva ME; Ozkan M; Parekh D; Paul M; Polack FP; Rath BA; Rodríguez AH; Sarrouf EB; Seale AC; Sertogullarindan B; Siqueira MM; Skręt-Magierło J; Stephan F; Talarek E; Tang JW; To KK; Torres A; Törün SH; Tran D; Uyeki TM; Van Zwol A; Vaudry W; Vidmar T; Yokota RT; Zarogoulidis P; ; Nguyen-Van-Tam JS
    Lancet Respir Med; 2014 May; 2(5):395-404. PubMed ID: 24815805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
    Venkatesan S; Myles PR; Bolton KJ; Muthuri SG; Al Khuwaitir T; Anovadiya AP; Azziz-Baumgartner E; Bajjou T; Bassetti M; Beovic B; Bertisch B; Bonmarin I; Booy R; Borja-Aburto VH; Burgmann H; Cao B; Carratala J; Chinbayar T; Cilloniz C; Denholm JT; Dominguez SR; Duarte PAD; Dubnov-Raz G; Fanella S; Gao Z; Gérardin P; Giannella M; Gubbels S; Herberg J; Higuera Iglesias AL; Hoeger PH; Hu XY; Islam QT; Jiménez MF; Keijzers G; Khalili H; Kusznierz G; Kuzman I; Langenegger E; Lankarani KB; Leo YS; Libster RP; Linko R; Madanat F; Maltezos E; Mamun A; Manabe T; Metan G; Mickiene A; Mikić D; Mohn KGI; Oliva ME; Ozkan M; Parekh D; Paul M; Rath BA; Refaey S; Rodríguez AH; Sertogullarindan B; Skręt-Magierło J; Somer A; Talarek E; Tang JW; To K; Tran D; Uyeki TM; Vaudry W; Vidmar T; Zarogoulidis P; ; Nguyen-Van-Tam JS
    J Infect Dis; 2020 Jan; 221(3):356-366. PubMed ID: 31314899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.
    Miller PE; Rambachan A; Hubbard RJ; Li J; Meyer AE; Stephens P; Mounts AW; Rolfes MA; Penn CR
    Influenza Other Respir Viruses; 2013 Sep; 7 Suppl 2(Suppl 2):82-86. PubMed ID: 24034490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitor resistance in influenza viruses.
    Reece PA
    J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
    Gubareva LV; Besselaar TG; Daniels RS; Fry A; Gregory V; Huang W; Hurt AC; Jorquera PA; Lackenby A; Leang SK; Lo J; Pereyaslov D; Rebelo-de-Andrade H; Siqueira MM; Takashita E; Odagiri T; Wang D; Zhang W; Meijer A
    Antiviral Res; 2017 Oct; 146():12-20. PubMed ID: 28802866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
    Huang SF; Fung CP; Perng DW; Wang FD
    J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.